Results 81 to 90 of about 1,200 (185)

[Experience with topical brimonidine (Alphagan (R) 0,2%) in the treatment of glaucomas]

open access: yes, 2000
Purpose: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2 %, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core  

Preoperative Preparation and Rehabilitation with Nonspecific Ulcerative Colitis

open access: yes, 2013
Дослідження проведено на ЗО хворих НВК. Встановлено, що це захворювання має інфекційне аутоімуноагресивне походження, про що свідчить ефективна етіопатогенетичнатерапія, яка включає: маса- лазік, метронідазоя, преднізолон; в м ікро клізмах: дипромак ...
Дудченко, Максим Андрійович   +2 more
core   +1 more source

Traitement des glaucomes par la brimonidine (Alphagan 0.2%).

open access: yes, 2000
PURPOSE: The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2%, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension Material-Methods: Brimonidine was administered alone or in ...
Dutrieux, C, Detry-Morel, M.
core  

Application of thermography in the diagnosis of the algodystrophic syndrome type I  in 42-year-old patient

open access: yes, 2014
Algodystrophic syndrome entity (type I) has not fully known pathogenesis and course. It is characterized by severe pain of the distal part of limb, oedema, vasomotor dysfunction and impaired efficiency.
Mróz, Józef   +7 more
core  

Sympatholytic Agents

open access: yes, 2017
Yury Khelemsky   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy